$13.2 Billion is the total value of FARALLON CAPITAL MANAGEMENT LLC's 99 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 39.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CELG | Buy | CELGENE CORP | $1,546,074,000 | +8.3% | 15,569,730 | +0.8% | 11.68% | +25.7% |
| AGN | Buy | ALLERGAN PLC | $1,049,288,000 | +526.7% | 6,235,000 | +523.5% | 7.92% | +627.7% |
| SPY | Sell | SPDR S&P 500 ETF TRput | $981,122,000 | -8.2% | 3,306,000 | -9.4% | 7.41% | +6.6% |
| AABA | Buy | ALTABA INC | $666,011,000 | -66.1% | 34,189,499 | +20.5% | 5.03% | -60.7% |
| WCG | Buy | WELLCARE HEALTH PLANS INC | $613,795,000 | -3.2% | 2,368,310 | +6.4% | 4.64% | +12.4% |
| WAB | Sell | WABTEC CORP | $450,633,000 | -4.4% | 6,270,986 | -4.5% | 3.40% | +11.0% |
| FIS | Buy | FIDELITY NATL INFORMATION SV | $405,663,000 | +16.3% | 3,055,609 | +7.5% | 3.06% | +35.1% |
| IQV | Buy | IQVIA HLDGS INC | $394,390,000 | -5.0% | 2,640,179 | +2.4% | 2.98% | +10.4% |
| BABA | Buy | ALIBABA GROUP HLDG LTDsponsored ads | $363,678,000 | +329.2% | 2,174,715 | +334.9% | 2.75% | +398.5% |
| IAC | New | IAC INTERACTIVECORP | $317,691,000 | – | 1,457,500 | +100.0% | 2.40% | – |
| GOOG | Buy | ALPHABET INCcap stk cl c | $304,795,000 | +98.3% | 250,037 | +75.8% | 2.30% | +130.2% |
| CHTR | Buy | CHARTER COMMUNICATIONS INC Ncl a | $290,672,000 | +5.0% | 705,309 | +0.7% | 2.20% | +21.9% |
| ANTM | Buy | ANTHEM INC | $255,198,000 | -13.9% | 1,062,883 | +1.2% | 1.93% | 0.0% |
| SHW | Sell | SHERWIN WILLIAMS CO | $247,415,000 | +15.9% | 449,952 | -3.4% | 1.87% | +34.7% |
| FB | Buy | FACEBOOK INCcl a | $242,815,000 | +39.1% | 1,363,514 | +50.8% | 1.83% | +61.6% |
| PLYA | PLAYA HOTELS & RESORTS NV | $239,652,000 | +1.6% | 30,606,930 | 0.0% | 1.81% | +17.9% | |
| INFO | Sell | IHS MARKIT LTD | $239,122,000 | +4.1% | 3,575,384 | -0.8% | 1.81% | +20.9% |
| V | Buy | VISA INC | $222,797,000 | +8.1% | 1,295,257 | +9.0% | 1.68% | +25.5% |
| EQIX | Sell | EQUINIX INC | $214,379,000 | +11.0% | 371,670 | -3.0% | 1.62% | +28.8% |
| SPGI | Sell | S&P GLOBAL INC | $203,900,000 | +6.5% | 832,314 | -1.0% | 1.54% | +23.6% |
| MSFT | Buy | MICROSOFT CORP | $196,626,000 | +16.7% | 1,414,272 | +12.5% | 1.48% | +35.5% |
| CTXS | Sell | CITRIX SYS INC | $183,419,000 | -2.5% | 1,900,323 | -0.8% | 1.38% | +13.2% |
| GD | Sell | GENERAL DYNAMICS CORP | $181,219,000 | -25.4% | 991,732 | -25.7% | 1.37% | -13.3% |
| ZAYO | Buy | ZAYO GROUP HLDGS INC | $167,610,000 | +80.6% | 4,944,247 | +75.3% | 1.27% | +109.6% |
| CI | Buy | CIGNA CORP NEW | $161,321,000 | -2.5% | 1,062,790 | +1.2% | 1.22% | +13.2% |
| BPL | Buy | BUCKEYE PARTNERS L Punit ltd partn | $160,251,000 | +442.3% | 3,900,000 | +441.8% | 1.21% | +530.2% |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $149,296,000 | -15.8% | 1,550,000 | +0.6% | 1.13% | -2.2% |
| PANW | New | PALO ALTO NETWORKS INC | $124,336,000 | – | 610,000 | +100.0% | 0.94% | – |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $120,630,000 | +51.1% | 1,500,000 | +36.4% | 0.91% | +75.5% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $109,655,000 | -21.9% | 6,025,000 | +5.2% | 0.83% | -9.3% |
| AZN | Sell | ASTRAZENECA PLCsponsored adr | $105,889,000 | -37.4% | 2,375,785 | -42.1% | 0.80% | -27.3% |
| MYOK | Buy | MYOKARDIA INC | $105,885,000 | +5.6% | 2,030,397 | +1.5% | 0.80% | +22.7% |
| SE | SEA LTDsponsored ads | $104,456,000 | -6.8% | 3,375,000 | 0.0% | 0.79% | +8.2% | |
| TRU | Sell | TRANSUNION | $101,804,000 | -17.2% | 1,255,138 | -24.9% | 0.77% | -3.9% |
| XLRN | Buy | ACCELERON PHARMA INC | $94,824,000 | -2.8% | 2,400,000 | +1.1% | 0.72% | +12.8% |
| EFX | Sell | EQUIFAX INC | $89,333,000 | -54.9% | 635,056 | -56.6% | 0.68% | -47.6% |
| GWR | Buy | GENESEE & WYO INCcl a | $86,493,000 | +11.6% | 782,673 | +1.0% | 0.65% | +29.6% |
| ALDR | New | ALDER BIOPHARMACEUTICALS INC | $78,552,000 | – | 4,165,000 | +100.0% | 0.59% | – |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $78,218,000 | +32.2% | 1,612,069 | +43.3% | 0.59% | +53.5% |
| TMCX | New | TRINITY MERGER CORP | $77,278,000 | – | 75,000,000 | +100.0% | 0.58% | – |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $76,555,000 | -5.5% | 1,274,212 | +32.7% | 0.58% | +9.7% |
| ABBV | New | ABBVIE INC | $75,720,000 | – | 1,000,000 | +100.0% | 0.57% | – |
| ZGNX | Sell | ZOGENIX INC | $70,070,000 | -26.7% | 1,750,000 | -12.5% | 0.53% | -15.0% |
| GRFS | Buy | GRIFOLS S Asp adr rep b nvt | $62,389,000 | -4.0% | 3,113,222 | +1.1% | 0.47% | +11.3% |
| BKNG | Sell | BOOKING HLDGS INC | $61,114,000 | -66.5% | 31,139 | -68.0% | 0.46% | -61.1% |
| CY | New | CYPRESS SEMICONDUCTOR CORP | $57,532,000 | – | 2,464,966 | +100.0% | 0.44% | – |
| CVS | Buy | CVS HEALTH CORP | $56,763,000 | +26.7% | 900,000 | +9.4% | 0.43% | +47.4% |
| RDUS | Buy | RADIUS HEALTH INC | $52,903,000 | +6.3% | 2,054,486 | +0.6% | 0.40% | +23.5% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $52,300,000 | -42.9% | 372,800 | -25.4% | 0.40% | -33.6% |
| ZYME | Sell | ZYMEWORKS INC | $42,941,000 | +11.1% | 1,731,500 | -1.4% | 0.32% | +29.1% |
| CARA | Buy | CARA THERAPEUTICS INC | $39,302,000 | +92.1% | 2,150,000 | +126.0% | 0.30% | +123.3% |
| S | Sell | SPRINT CORPORATION | $38,465,000 | -45.2% | 6,234,186 | -41.6% | 0.29% | -36.2% |
| PGNX | Buy | PROGENICS PHARMACEUTICALS IN | $37,154,000 | +8.6% | 7,350,000 | +32.6% | 0.28% | +26.6% |
| FGEN | Sell | FIBROGEN INC | $36,980,000 | -51.9% | 1,000,000 | -41.2% | 0.28% | -44.2% |
| NXPI | Sell | NXP SEMICONDUCTORS N V | $35,464,000 | -15.5% | 325,000 | -24.4% | 0.27% | -1.8% |
| RC | Sell | READY CAP CORP | $35,106,000 | +5.0% | 2,205,132 | -1.7% | 0.26% | +22.1% |
| FATE | Sell | FATE THERAPEUTICS INC | $34,943,000 | -31.1% | 2,250,000 | -10.0% | 0.26% | -20.0% |
| UBER | New | UBER TECHNOLOGIES INCput | $33,593,000 | – | 1,102,500 | +100.0% | 0.25% | – |
| New | CYPRESS SEMICONDUCTOR CORPnote 4.500% 1/1 | $32,577,000 | – | 18,645,000 | +100.0% | 0.25% | – | |
| EXEL | Sell | EXELIXIS INC | $30,949,000 | -51.7% | 1,750,000 | -41.7% | 0.23% | -43.9% |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $30,329,000 | -63.2% | 2,000,600 | -52.9% | 0.23% | -57.3% |
| ZEAL | Buy | ZEALAND PHARMA A Ssponsored adr | $25,614,000 | +18.9% | 1,010,000 | +1.0% | 0.19% | +37.9% |
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $25,455,000 | – | 750,000 | +100.0% | 0.19% | – |
| Buy | PTC THERAPEUTICS INCnote 3.000% 8/1 | $25,210,000 | -5.6% | 24,176,000 | +0.2% | 0.19% | +9.2% | |
| NVTA | Buy | INVITAE CORP | $25,051,000 | +18.4% | 1,300,000 | +44.4% | 0.19% | +37.0% |
| PTCT | Buy | PTC THERAPEUTICS INC | $24,587,000 | -8.9% | 726,986 | +21.2% | 0.19% | +5.7% |
| SYMC | New | SYMANTEC CORP | $24,339,000 | – | 1,030,000 | +100.0% | 0.18% | – |
| VCYT | Buy | VERACYTE INC | $24,000,000 | +140.5% | 1,000,000 | +185.7% | 0.18% | +178.5% |
| STML | Buy | STEMLINE THERAPEUTICS INC | $23,943,000 | +4.2% | 2,300,000 | +53.3% | 0.18% | +21.5% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $23,373,000 | -77.2% | 300,000 | -69.8% | 0.18% | -73.5% |
| CRSP | Buy | CRISPR THERAPEUTICS AGnamen akt | $22,969,000 | -2.5% | 560,367 | +12.1% | 0.17% | +13.1% |
| AVRO | Buy | AVROBIO INC | $21,886,000 | +29.9% | 1,550,000 | +49.6% | 0.16% | +50.0% |
| ONCE | Sell | SPARK THERAPEUTICS INC | $21,336,000 | -72.9% | 220,000 | -71.4% | 0.16% | -68.6% |
| PVTL | New | PIVOTAL SOFTWARE INC | $21,336,000 | – | 1,430,000 | +100.0% | 0.16% | – |
| ARWR | Sell | ARROWHEAD PHARMACEUTICALS IN | $18,317,000 | -65.4% | 650,000 | -67.5% | 0.14% | -60.0% |
| PTGX | PROTAGONIST THERAPEUTICS INC | $18,015,000 | -0.8% | 1,500,000 | 0.0% | 0.14% | +15.3% | |
| Buy | SOLARCITY CORPnote 1.625%11/0 | $17,175,000 | +223.8% | 17,370,000 | +215.8% | 0.13% | +282.4% | |
| TCDA | New | TRICIDA INC | $15,435,000 | – | 500,000 | +100.0% | 0.12% | – |
| RETA | Sell | REATA PHARMACEUTICALS INCcl a | $14,618,000 | -80.6% | 182,060 | -77.2% | 0.11% | -77.6% |
| MLNX | New | MELLANOX TECHNOLOGIES LTD | $13,699,000 | – | 125,000 | +100.0% | 0.10% | – |
| CCXI | Buy | CHEMOCENTRYX INC | $13,651,000 | -26.6% | 2,013,396 | +0.7% | 0.10% | -14.9% |
| QTNT | Sell | QUOTIENT LTD | $13,209,000 | -43.5% | 1,700,000 | -32.0% | 0.10% | -34.2% |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $12,597,000 | – | 350,000 | +100.0% | 0.10% | – |
| EIGR | Buy | EIGER BIOPHARMACEUTICALS INC | $11,531,000 | +8.8% | 1,125,000 | +12.5% | 0.09% | +26.1% |
| SVRA | Buy | SAVARA INC | $9,304,000 | +13.0% | 3,510,787 | +1.0% | 0.07% | +29.6% |
| Buy | CLOVIS ONCOLOGY INCnote 1.250% 5/0 | $8,261,000 | -29.3% | 18,801,000 | +0.3% | 0.06% | -18.4% | |
| AXSM | New | AXSOME THERAPEUTICS INC | $8,096,000 | – | 400,000 | +100.0% | 0.06% | – |
| XGN | New | EXAGEN INC | $5,628,000 | – | 363,336 | +100.0% | 0.04% | – |
| PFNX | PFENEX INC | $5,064,000 | +25.2% | 600,000 | 0.0% | 0.04% | +46.2% | |
| CYCN | Sell | CYCLERION THERAPEUTICS INC | $4,565,000 | -26.7% | 376,628 | -30.8% | 0.03% | -17.1% |
| QURE | Buy | UNIQURE NV | $3,972,000 | -49.2% | 100,922 | +0.9% | 0.03% | -41.2% |
| GCVRZ | SANOFIright 12/31/2020 | $3,892,000 | +9.6% | 6,827,805 | 0.0% | 0.03% | +26.1% | |
| New | DERMTECH INC | $3,446,000 | – | 615,385 | +100.0% | 0.03% | – | |
| PHAS | Buy | PHASEBIO PHARMACEUTICALS INC | $3,369,000 | -66.1% | 807,928 | +6.7% | 0.02% | -61.5% |
| APTX | Buy | APTINYX INC | $2,353,000 | +5.1% | 674,141 | +0.6% | 0.02% | +20.0% |
| GOSS | Buy | GOSSAMER BIO INC | $1,691,000 | -23.8% | 100,712 | +0.7% | 0.01% | -7.1% |
| IIVI | New | II VI INC | $1,679,000 | – | 47,687 | +100.0% | 0.01% | – |
| ZFGN | Buy | ZAFGEN INC | $1,336,000 | -37.6% | 1,808,360 | +0.5% | 0.01% | -28.6% |
| RADIUS HEALTH INCnote 3.000% 9/0 | $1,140,000 | +0.7% | 1,250,000 | 0.0% | 0.01% | +28.6% | ||
| OXY | Exit | OCCIDENTAL PETE CORP | $0 | – | -20,000 | -100.0% | -0.01% | – |
| ADPT | Exit | ADAPTIVE BIOTECHNOLOGIES COR | $0 | – | -25,000 | -100.0% | -0.01% | – |
| ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -100,000 | -100.0% | -0.01% | – |
| AKRO | Exit | AKERO THERAPEUTICS INC | $0 | – | -150,000 | -100.0% | -0.02% | – |
| PSNL | Exit | PERSONALIS INC | $0 | – | -184,932 | -100.0% | -0.03% | – |
| MIST | Exit | MILESTONE PHARMACEUTICALS IN | $0 | – | -250,000 | -100.0% | -0.04% | – |
| TWST | Exit | TWIST BIOSCIENCE CORP | $0 | – | -307,055 | -100.0% | -0.06% | – |
| VOYA | Exit | VOYA FINL INC | $0 | – | -185,000 | -100.0% | -0.07% | – |
| NSTG | Exit | NANOSTRING TECHNOLOGIES INC | $0 | – | -350,000 | -100.0% | -0.07% | – |
| VYGR | Exit | VOYAGER THERAPEUTICS INC | $0 | – | -750,000 | -100.0% | -0.13% | – |
| SINA | Exit | SINA CORPord | $0 | – | -510,000 | -100.0% | -0.14% | – |
| CDXS | Exit | CODEXIS INC | $0 | – | -1,250,000 | -100.0% | -0.15% | – |
| FOXA | Exit | FOX CORP | $0 | – | -836,400 | -100.0% | -0.20% | – |
| TMUS | Exit | T MOBILE US INC | $0 | – | -425,780 | -100.0% | -0.20% | – |
| FDC | Exit | FIRST DATA CORP NEW | $0 | – | -1,425,000 | -100.0% | -0.25% | – |
| FOX | Exit | FOX CORP | $0 | – | -1,182,500 | -100.0% | -0.28% | – |
| LBTYA | Exit | LIBERTY GLOBAL PLC | $0 | – | -2,083,977 | -100.0% | -0.37% | – |
| NVCR | Exit | NOVOCURE LTD | $0 | – | -1,200,000 | -100.0% | -0.49% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -500,000 | -100.0% | -0.49% | – |
| LBTYK | Exit | LIBERTY GLOBAL PLC | $0 | – | -3,675,974 | -100.0% | -0.63% | – |
| ARRY | Exit | ARRAY BIOPHARMA INC | $0 | – | -8,500,000 | -100.0% | -2.56% | – |
| APC | Exit | ANADARKO PETE CORP | $0 | – | -10,465,000 | -100.0% | -4.80% | – |
| RHT | Exit | RED HAT INC | $0 | – | -5,132,800 | -100.0% | -6.27% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 41 | Q3 2023 | 3.7% |
| RADIUS HEALTH INC | 33 | Q2 2022 | 1.7% |
| GRIFOLS S A | 33 | Q4 2021 | 0.9% |
| ALPHABET INC | 32 | Q3 2023 | 4.2% |
| SPDR S&P 500 ETF TR | 31 | Q3 2023 | 25.3% |
| VISA INC | 30 | Q3 2023 | 2.9% |
| WABTEC CORP | 27 | Q3 2023 | 3.6% |
| EXELIXIS INC | 27 | Q3 2023 | 2.8% |
| ELEVANCE HEALTH INC | 26 | Q3 2023 | 2.6% |
| SAVARA INC | 26 | Q3 2023 | 0.3% |
View FARALLON CAPITAL MANAGEMENT LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Atento S.A. | March 15, 2023 | 2,230,357 | 15.4% |
| Metals Acquisition Corp | February 07, 2023 | 2,489,700 | 9.4% |
| Inflection Point Acquisition Corp. | February 06, 2023 | 1,900,000 | 5.8% |
| AMYRIS, INC. | February 24, 2022 | 1,068,904 | 0.3% |
| Swiftmerge Acquisition Corp. | February 14, 2022 | 291,060 | 1.3% |
| Caribou Biosciences, Inc. | February 11, 2022 | 2,428,150 | 4.0% |
| ENANTA PHARMACEUTICALS INC | February 11, 2022 | 287,000 | 1.4% |
| Protagonist Therapeutics, Inc | February 11, 2022 | 387,051 | 0.8% |
| Solid Power, Inc. | February 11, 2022 | ? | ? |
| Better Therapeutics, Inc. | February 09, 2022 | 124,065 | 0.5% |
View FARALLON CAPITAL MANAGEMENT LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR | 2024-02-14 |
| 13F-HR/A | 2024-02-12 |
| SC 13G/A | 2024-02-01 |
| SC 13G/A | 2024-01-23 |
View FARALLON CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.